PRTN3 and rheumatoid arthritis: The same pattern was also recently demonstrated by Brink et al. [25] where antibodies against arginine-containing peptides from RA autoantigens antedated development of citrulline-specific ACPA in serum samples taken from individuals years before they went on to develop symptomatic RA.